Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on October 14, 2004

Arteriosclerosis, Thrombosis, and Vascular Biology. 2004
Published online before print October 14, 2004, doi: 10.1161/01.ATV.0000147766.68987.0d
A more recent version of this article appeared on December 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/12/2277    most recent
01.ATV.0000147766.68987.0dv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Freedman, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Freedman, N. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Submitted on May 14, 2004
Accepted on October 5, 2004

Vein Graft Neointimal Hyperplasia Is Exacerbated by Tumor Necrosis Factor Receptor-1 Signaling in Graft-Intrinsic Cells

Lisheng Zhang ; Karsten Peppel *; Leigh Brian ; Lynn Chien ; and Neil J. Freedman

From Duke University Department of Medicine (Cardiology), Duke University Medical Center, Durham, NC.

* To whom correspondence should be addressed. E-mail: karsten.peppel{at}duke.edu.

Objective--Vein graft remodeling and neointimal hyperplasia involve inflammation, graft-intrinsic cells, and recruitment of vascular progenitor cells. We sought to examine if the inflammatory cytokine tumor necrosis factor (TNF) affects vein graft remodeling via its p55 TNF receptor-1 (p55).

Methods and Results--Inferior vena cava-to-carotid artery interposition grafting was performed between p55-/- and congenic (C57Bl/6) wild-type (WT) mice. Immunofluorescence revealed TNF in early (2-week) vein grafts. Six weeks postoperatively, luminal and medial areas were indistinguishable among all vein graft groups. However, neointimal area was reduced in p55-/- grafts: by 40% in p55-/- grafts placed in p55-/- recipients, and by 21% in p55-/- grafts placed in WT recipients, compared with WT grafts in WT recipients (P<0.05). In 2-week-old vein grafts, p55 deficiency reduced intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and monocyte chemoattractant protein-1 expression by 50% to 60%, and increased the extent of graft endothelialization. In vitro, TNF promoted chemokine expression and [3H]thymidine incorporation in vascular smooth muscle cells (SMCs) from WT, but not from p55-/- mice. However, responses of WT and p55-/- SMCs to other growth factors were equivalent.

Conclusions--Signaling via p55, in vein graft-intrinsic cells, contributes to the pathogenesis of vein graft neointimal hyperplasia.
Key words: vascular remodeling • inflammation • mouse models • smooth muscle cells • tumor necrosis factor




This article has been cited by other articles:


Home page
 Asian Cardiovasc. Thorac. Ann.Home page
S.-A. Hassantash, B. Bikdeli, S. Kalantarian, M. Sadeghian, and H. Afshar
Pathophysiology of Aortocoronary Saphenous Vein Bypass Graft Disease
Asian Cardiovasc Thorac Ann, August 1, 2008; 16(4): 331 - 336.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. Zhang, P. Sivashanmugam, J.-H. Wu, L. Brian, S. T. Exum, N. J. Freedman, and K. Peppel
Tumor Necrosis Factor Receptor-2 Signaling Attenuates Vein Graft Neointima Formation by Promoting Endothelial Recovery
Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 284 - 289.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. H. Giangrande, J. Zhang, A. Tanner, A. D. Eckhart, R. E. Rempel, E. R. Andrechek, J. M. Layzer, J. R. Keys, P.-O. Hagen, J. R. Nevins, et al.
Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia
PNAS, August 7, 2007; 104(32): 12988 - 12993.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. Zhang, K. Peppel, P. Sivashanmugam, E. S. Orman, L. Brian, S. T. Exum, and N. J. Freedman
Expression of Tumor Necrosis Factor Receptor-1 in Arterial Wall Cells Promotes Atherosclerosis
Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1087 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-H. Wu, R. Goswami, X. Cai, S. T. Exum, X. Huang, L. Zhang, L. Brian, R. T. Premont, K. Peppel, and N. J. Freedman
Regulation of the Platelet-derived Growth Factor Receptor-beta by G Protein-coupled Receptor Kinase-5 in Vascular Smooth Muscle Cells Involves the Phosphatase Shp2
J. Biol. Chem., December 8, 2006; 281(49): 37758 - 37772.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. P. Salzberg, F. Filsoufi, A. Anyanwu, K. von Harbou, E. Karlof, A. Carpentier, H. M. Dansky, and D. H. Adams
Increased Neointimal Formation After Surgical Vein Grafting in a Murine Model of Type 2 Diabetes
Circulation, July 4, 2006; 114(1_suppl): I-302 - I-307.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
E. W. Raines and N. Ferri
Thematic Review Series: The Immune System and Atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease
J. Lipid Res., June 1, 2005; 46(6): 1081 - 1092.
[Abstract] [Full Text] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.